CN103479835A - Traditional Chinese medicine for treating liver cirrhosis - Google Patents

Traditional Chinese medicine for treating liver cirrhosis Download PDF

Info

Publication number
CN103479835A
CN103479835A CN201310459180.5A CN201310459180A CN103479835A CN 103479835 A CN103479835 A CN 103479835A CN 201310459180 A CN201310459180 A CN 201310459180A CN 103479835 A CN103479835 A CN 103479835A
Authority
CN
China
Prior art keywords
liver cirrhosis
chinese medicine
traditional chinese
radix
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310459180.5A
Other languages
Chinese (zh)
Inventor
秦福玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310459180.5A priority Critical patent/CN103479835A/en
Publication of CN103479835A publication Critical patent/CN103479835A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine for treating liver cirrhosis. The traditional Chinese medicine is prepared from the raw materials in proportion by weight as follows: 30 to 40 of Chinese thorowax roots, 30 to 40 of lobelia chinensis, 10 to 20 of red ginseng, 12 to 20 of deep-fried rhizoma atractylodis, 20 to 30 of astragalus, 5 to 15 of tangerine peel, 5 to 13 of ligusticum wallichii, 8 to 17 of cyperus rotundus, 5 to 16 of bitter orange and 20 to 30 of angelica dahurica. According to the traditional Chinese medicine for treating the liver cirrhosis, the Chinese thorowax roots and the lobelia chinensis are used as main medicines and are matched with other adjuvants, and the main medicines and the adjuvants are influenced mutually and take a synergistic effect, so that the traditional Chinese medicine for treating the liver cirrhosis takes good effects of heat clearing, toxicity removing, diuresis promoting, blood activating and stasis dissolving and has a good curative effect on the liver cirrhosis and chronic hepatitis; and the traditional Chinese medicine for treating the liver cirrhosis adopts simple raw materials, is low in cost and is convenient to take.

Description

A kind of Chinese medicine for the treatment of liver cirrhosis
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine for the treatment of liver cirrhosis.
Background technology
Liver cirrhosis (hepatic cirrhosis) is clinical common chronic progressive external hepatopathy, or diffusivity hepatic injury that repeated action form long-term by one or more causes of disease.In China, great majority are posthepatitic cirrhosis, and small part is alcoholic cirrhosis and Cirrhosis In Schistosomiasis.Hepatic necrosis, remaining hepatocyte nodular regeneration, connective tissue proliferation and fiber are arranged widely every formation on histopathology, cause lobules of liver structural deterioration and pseudolobuli to form, liver distortion gradually, hardening and develop into liver cirrhosis.But in early days due to liver compensation non-evident sympton more by force, it is main manifestations that stage be take liver function injury and portal hypertension, and having multisystem to get involved, the complication such as upper gastrointestinal hemorrhage, hepatic encephalopathy, secondary infection, hypersplenism, ascites, canceration often appear late period.The medicine for the treatment of liver cirrhosis is numerous at present, for example publication number is: CN1965975, name are called the Chinese invention patent application of " the good effect liquid of liver cirrhosis ", the invention belongs to Chinese herbal and crude drugs preparations, be specifically related to a kind of liver cirrhosis, sclerosis ascites for the treatment of, motherland's medical science is called the good effect liquid of liver cirrhosis of the liver rump, " tympanites " class.Its ingredients: Radix Bupleuri, Rhizoma Cyperi, Fructus Aurantii, Cortex Magnoliae Officinalis, Cortex Moutan, Radix Notoginseng, keep public affairs, the red Radix Paeoniae Alba, Squama Manis, Carapax Trionycis, Carapax et Plastrum Testudinis, the Rhizoma Atractylodis Macrocephalae, Fructus Crataegi, Endothelium Corneum Gigeriae Galli, goldenseal, Herba Hedyotidis Diffusae, this medicine must be processed, makes with extra care, the science compatibility, can reduce toxic and side effects, strengthen effect.Said herbal medicine processing is fried into to medicinal liquid standby.Take every day three times, add decoction being taken warmly 200-300 milliliter at every turn.Period in a medicine can more take once flexibly according to the state of an illness in one hour, and the state of an illness takes once after alleviating in 4-8 hour.Dose is according to the strong and weak increase and decrease of patient body.Period in a medicine is avoided tobacco and wine, sad, raw and cold, angry, sexual life.Beneficial effect is: curative effect better, lower, the instant effect of expenses for medicine, short treating period, toxic and side effects is little.But the compatibility of this medicine is comparatively complicated.
Summary of the invention
The technical problem to be solved in the present invention is to provide that a kind of compatibility is comparatively simple, the Chinese medicine of safe without toxic side effect, eutherapeutic treatment liver cirrhosis.
For solving the problems of the technologies described above, the present invention by the following technical solutions:
The present invention treats the Chinese medicine of liver cirrhosis, is to be made by the raw material of following weight proportioning:
Radix Bupleuri 30~40, Herba Lobeliae Chinensis 30~40, Radix Ginseng Rubra 10~20, Rhizoma Atractylodis Macrocephalae preparata 12~20, the Radix Astragali 20~30, Pericarpium Citri Reticulatae 5~15, Rhizoma Chuanxiong 5~13, Rhizoma Cyperi 8~17, Fructus Aurantii 5~16, the Radix Angelicae Dahuricae 20~30.
The preferred weight proportioning of each raw material is:
Radix Bupleuri 32~38, Herba Lobeliae Chinensis 32~38, Radix Ginseng Rubra 12~18, Rhizoma Atractylodis Macrocephalae preparata 15~18, the Radix Astragali 22~28, Pericarpium Citri Reticulatae 8~12, Rhizoma Chuanxiong 7~11, Rhizoma Cyperi 10~14, Fructus Aurantii 8~14, the Radix Angelicae Dahuricae 22~28.
The optimum weight proportioning of each raw material is:
Radix Bupleuri 35, Herba Lobeliae Chinensis 34, Radix Ginseng Rubra 15, Rhizoma Atractylodis Macrocephalae preparata 16, the Radix Astragali 25, Pericarpium Citri Reticulatae 10, Rhizoma Chuanxiong 8, Rhizoma Cyperi 12, Fructus Aurantii 10, the Radix Angelicae Dahuricae 25.
The preparation method that the present invention treats the Chinese medicine of liver cirrhosis is: take by weight ratio raw material Radix Bupleuri, Herba Lobeliae Chinensis, Radix Ginseng Rubra, Rhizoma Atractylodis Macrocephalae preparata, the Radix Astragali, Pericarpium Citri Reticulatae, Rhizoma Chuanxiong, Rhizoma Cyperi, Fructus Aurantii, the Radix Angelicae Dahuricae, add the decocting of 6~10 times of raw material weights to boil, the water rear slow fire that boils boils 40~60 minutes, leach medicinal liquid, obtain.
The instructions of taking that the present invention treats the Chinese medicine of liver cirrhosis is: oral, every day twice, each serving 200~300 grams, take 2~4 months.
It is principal agent that the Chinese medicine that the present invention treats liver cirrhosis be take Radix Bupleuri and Herba Lobeliae Chinensis, other accessory drugs of arranging in pairs or groups, they influence each other, synergism, thereby play good clearing heat, detoxicating, dispelling dampness, blood circulation promoting and blood stasis dispelling, effect, liver cirrhosis and chronic hepatitis are had to good curative effect, and its raw material is simple, with low cost, taking convenience.
The specific embodiment
Below with embodiment, the invention will be further described, but the present invention is not limited to these embodiment.
Below umber described in each embodiment be weight portion.
Embodiment 1
The drug weight proportioning:
30 parts of Radix Bupleuri, 30 parts of Herba Lobeliae Chinensis, 10 parts of Radix Ginseng Rubra, 12 parts of Rhizoma Atractylodis Macrocephalae preparatas, 20 parts of the Radixs Astragali, 5 parts of Pericarpium Citri Reticulataes, 5 parts of Rhizoma Chuanxiongs, 8 parts of Rhizoma Cyperis, 5 parts of Fructus Aurantiis, 20 parts of the Radixs Angelicae Dahuricae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 6 times of raw material weights to boil, the water rear slow fire that boils boils 40 minutes, leaches medicinal liquid, obtains.
Embodiment 2
The drug weight proportioning:
40 parts of Radix Bupleuri, 40 parts of Herba Lobeliae Chinensis, 20 parts of Radix Ginseng Rubra, 20 parts of Rhizoma Atractylodis Macrocephalae preparatas, 30 parts of the Radixs Astragali, 15 parts of Pericarpium Citri Reticulataes, 13 parts of Rhizoma Chuanxiongs, 17 parts of Rhizoma Cyperis, 16 parts of Fructus Aurantiis, 30 parts of the Radixs Angelicae Dahuricae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 10 times of raw material weights to boil, the water rear slow fire that boils boils 60 minutes, leaches medicinal liquid, obtains.
Embodiment 3
The drug weight proportioning:
35 parts of Radix Bupleuri, 34 parts of Herba Lobeliae Chinensis, 15 parts of Radix Ginseng Rubra, 16 parts of Rhizoma Atractylodis Macrocephalae preparatas, 25 parts of the Radixs Astragali, 10 parts of Pericarpium Citri Reticulataes, 8 parts of Rhizoma Chuanxiongs, 12 parts of Rhizoma Cyperis, 10 parts of Fructus Aurantiis, 25 parts of the Radixs Angelicae Dahuricae.
Preparation method:
Take raw material by above-mentioned weight proportion, add the decocting of 8 times of raw material weights to boil, the water rear slow fire that boils boils 50 minutes, leaches medicinal liquid, obtains.
Experimental example:
Below example is further set forth the beneficial effect that the present invention treats the Chinese medicine of liver cirrhosis by experiment.
1, experiment crowd:
Be divided into A, two experimental grouies of B:
A group: Male Patients With Cirrhosis 78 examples; 40~55 years old age.
B group: liver cirrhosis female patient 63 examples; 45~55 years old age.
2, drug administration method:
Chinese medicine every day of the treatment liver cirrhosis that the oral embodiment of the present invention 3 makes 2 times, each serving 300 grams, serve on 3 months.
3, efficacy evaluation:
(1) invalid: with take medicine before compare, without significant change.
(2) produce effects: therapeutic effect is obvious.
4, therapeutic effect:
Figure BDA0000390494410000031

Claims (3)

1. a Chinese medicine for the treatment of liver cirrhosis it is characterized in that being made by the raw material of following weight proportioning:
Radix Bupleuri 30~40, Herba Lobeliae Chinensis 30~40, Radix Ginseng Rubra 10~20, Rhizoma Atractylodis Macrocephalae preparata 12~20, the Radix Astragali 20~30, Pericarpium Citri Reticulatae 5~15, Rhizoma Chuanxiong 5~13, Rhizoma Cyperi 8~17, Fructus Aurantii 5~16, the Radix Angelicae Dahuricae 20~30.
2. the Chinese medicine for the treatment of liver cirrhosis according to claim 1 is characterized in that the weight proportion of each raw material is:
Radix Bupleuri 32~38, Herba Lobeliae Chinensis 32~38, Radix Ginseng Rubra 12~18, Rhizoma Atractylodis Macrocephalae preparata 15~18, the Radix Astragali 22~28, Pericarpium Citri Reticulatae 8~12, Rhizoma Chuanxiong 7~11, Rhizoma Cyperi 10~14, Fructus Aurantii 8~14, the Radix Angelicae Dahuricae 22~28.
3. the Chinese medicine for the treatment of liver cirrhosis according to claim 2 is characterized in that the weight proportion of each raw material is:
Radix Bupleuri 35, Herba Lobeliae Chinensis 34, Radix Ginseng Rubra 15, Rhizoma Atractylodis Macrocephalae preparata 16, the Radix Astragali 25, Pericarpium Citri Reticulatae 10, Rhizoma Chuanxiong 8, Rhizoma Cyperi 12, Fructus Aurantii 10, the Radix Angelicae Dahuricae 25.
CN201310459180.5A 2013-09-29 2013-09-29 Traditional Chinese medicine for treating liver cirrhosis Pending CN103479835A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310459180.5A CN103479835A (en) 2013-09-29 2013-09-29 Traditional Chinese medicine for treating liver cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310459180.5A CN103479835A (en) 2013-09-29 2013-09-29 Traditional Chinese medicine for treating liver cirrhosis

Publications (1)

Publication Number Publication Date
CN103479835A true CN103479835A (en) 2014-01-01

Family

ID=49820648

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310459180.5A Pending CN103479835A (en) 2013-09-29 2013-09-29 Traditional Chinese medicine for treating liver cirrhosis

Country Status (1)

Country Link
CN (1) CN103479835A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523798A (en) * 2014-12-02 2015-04-22 陈永华 Traditional Chinese medicine composition for treating chronic liver disease and preparation method thereof
CN105126043A (en) * 2015-10-27 2015-12-09 陈远征 Traditional Chinese medicine composition for treating liver cirrhosis and application thereof
CN111888418A (en) * 2020-08-18 2020-11-06 伍凤英 Chinese medicinal composition for preventing and treating hepatitis and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015647A (en) * 2007-01-10 2007-08-15 李济仁 Traditional Chinese medicine composition for treating hepatocirrhosis and liver ascites
CN101912583A (en) * 2010-08-24 2010-12-15 威海东宝制药有限公司 Medicament for treating chronic hepatitis and early-phase hepatocirrhosis and preparation method thereof
CN101972424A (en) * 2010-10-18 2011-02-16 孙晓东 Traditional Chinese medicine for treating cirrhosis ascites

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101015647A (en) * 2007-01-10 2007-08-15 李济仁 Traditional Chinese medicine composition for treating hepatocirrhosis and liver ascites
CN101912583A (en) * 2010-08-24 2010-12-15 威海东宝制药有限公司 Medicament for treating chronic hepatitis and early-phase hepatocirrhosis and preparation method thereof
CN101972424A (en) * 2010-10-18 2011-02-16 孙晓东 Traditional Chinese medicine for treating cirrhosis ascites

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
不详: "《养生堂》大国医 陈文伯", 《360DOC个人图书馆 HTTP://WWW.360DOC.COMCONTENT120512012006953_210427643.SHTML》 *
杨寿元: "试论中医治疗肝硬化", 《江苏医药(中医分册)》 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104523798A (en) * 2014-12-02 2015-04-22 陈永华 Traditional Chinese medicine composition for treating chronic liver disease and preparation method thereof
CN105126043A (en) * 2015-10-27 2015-12-09 陈远征 Traditional Chinese medicine composition for treating liver cirrhosis and application thereof
CN111888418A (en) * 2020-08-18 2020-11-06 伍凤英 Chinese medicinal composition for preventing and treating hepatitis and preparation method thereof

Similar Documents

Publication Publication Date Title
CN101129620A (en) Traditional Chinese medicine for treating nasosinusitis headache
CN103705866A (en) Traditional Chinese medicine composition for treating hypomenorrhea
CN102872381B (en) Traditional Chinese medicine composition for treating epidemic parotitis
CN101991752A (en) Traditional Chinese medicine formula for treating gout
CN103316305B (en) Traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof
CN102988616B (en) Chinese medicinal composition for treating anemia
CN100998722A (en) Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia
CN103479835A (en) Traditional Chinese medicine for treating liver cirrhosis
CN104189463A (en) Rheumatism pain medicinal liquor and preparation method thereof
CN104288496A (en) Traditional Chinese medicine composition for treating constipation
CN101357184A (en) Chinese traditional medicine for treating hepatosis and preparation method thereof
CN101130053A (en) Traditional Chinese medicine for treating exogenous injury type blood stasis headache
CN101167932A (en) Traditional Chinese medicine for treating chronic hepatitis B
CN1903299A (en) Traditional Chinese medicine decoction for treating-ache and expelling atagnate
CN101926903A (en) Chinese medicine preparation for curing facial paralysis
CN102416146B (en) Chinese medicinal composition for treating amenorrhea
CN104606514A (en) Traditional Chinese medicine composition for treating kidney deficiency type tinnitus
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103550679A (en) Traditional Chinese medicine formula for treatment of lithangiuria
CN103550533B (en) Chinese medicine composition for treating headache during menstruation
CN102114211B (en) Chinese herbal medicine for treating hepatopathy
CN102697902B (en) Chinese medicine composition for treating chronic rhinitis
CN105381289A (en) Pharmaceutical composition for treating abnormal menstruation
CN105456924A (en) Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof
CN104127602A (en) Traditional Chinese medicine for treating fatty liver

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140101